Terry G J Derks Selected Research

Glycogen Storage Disease (Glycogenosis)

1/2022	Efficacy and safety of empagliflozin in glycogen storage disease type Ib: Data from an international questionnaire.
11/2021	Modeling Phenotypic Heterogeneity of Glycogen Storage Disease Type 1a Liver Disease in Mice by Somatic CRISPR/CRISPR-associated protein 9-Mediated Gene Editing.
7/2021	Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report.
1/2021	Effects of acute nutritional ketosis during exercise in adults with glycogen storage disease type IIIa are phenotype-specific: An investigator-initiated, randomized, crossover study.
1/2021	Impaired Very-Low-Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia.
1/2020	Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib.
1/2020	Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor.
1/2020	Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels.
12/2017	Hepatocytes contribute to residual glucose production in a mouse model for glycogen storage disease type Ia.
5/2015	Evaluation of glycogen storage disease as a cause of ketotic hypoglycemia in children.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Terry G J Derks Research Topics

Disease

12	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 06/2008
11	Medium chain acyl CoA dehydrogenase deficiency 11/2022 - 08/2005
10	Glycogen Storage Disease (Glycogenosis) 01/2022 - 05/2015
7	Hepatorenal form of glycogen storage disease 08/2022 - 05/2013
5	Glycogen Storage Disease IB 01/2022 - 01/2020
4	Neutropenia 01/2022 - 01/2020
4	Phenylketonurias (Phenylketonuria) 03/2016 - 07/2014
3	Metabolic Diseases (Metabolic Disease) 01/2022 - 01/2017
3	Inborn Errors Metabolism (Inborn Errors of Metabolism) 01/2021 - 09/2019
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2020
2	Multiple Acyl Coenzyme A Dehydrogenase Deficiency 01/2021 - 01/2019
2	Hypertriglyceridemia 01/2021 - 05/2015
2	Glycogen Storage Disease Type III (Cori's Disease) 01/2020 - 01/2016
2	Osteoporosis 01/2020 - 01/2017
2	Cardiomyopathies (Cardiomyopathy) 01/2019 - 10/2018
2	Tyrosinemias (Tyrosinemia) 01/2017 - 01/2015
1	Fatigue 11/2022
1	Myalgia 11/2022
1	Liver Cell Adenoma (Hepatocellular Adenoma) 08/2022
1	Reinfection 01/2022
1	Abscess 01/2022
1	Anemia 01/2022
1	Liver Diseases (Liver Disease) 11/2021
1	Enterocolitis 07/2021
1	Crohn Disease (Crohn's Disease) 07/2021
1	Fatty Liver 01/2021
1	Portal Hypertension 01/2021
1	Ketosis 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Wounds and Injuries (Trauma) 01/2020
1	Cardiomegaly (Heart Hypertrophy) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Rare Diseases (Rare Disease) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Inflammation (Inflammations) 01/2020
1	VLCAD deficiency 01/2019
1	Muscular Diseases (Myopathy) 01/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2018
1	Sudden Death 12/2017
1	Metabolic Bone Diseases (Osteopenia) 01/2017
1	Adenoma (Adenomas) 01/2017
1	Obesity 12/2015
1	Hyperlipidemias (Hyperlipidemia) 05/2015
1	Glycogen Storage Disease Type Ix 05/2015
1	Disease Progression 10/2014

Drug/Important Bio-Agent (IBA)

9	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2008
9	Acyl-CoA Dehydrogenase (Medium-Chain Acyl-Coenzyme A Dehydrogenase)IBA 01/2019 - 08/2005
8	EnzymesIBA 10/2021 - 05/2012
6	Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA 08/2022 - 01/2017
5	Triglycerides (Triacylglycerol)IBA 08/2022 - 09/2005
5	empagliflozinIBA 01/2022 - 01/2020
5	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 08/2005
4	KetonesIBA 01/2021 - 05/2015
4	Phenylalanine (L-Phenylalanine)FDA Link 01/2017 - 01/2015
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 11/2021 - 09/2014
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021 - 01/2019
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 01/2017
3	Starch (Cornstarch)IBA 01/2021 - 05/2013
2	VLDL LipoproteinsIBA 01/2021 - 09/2005
2	Biomarkers (Surrogate Marker)IBA 11/2020 - 05/2015
2	GlycogenIBA 01/2020 - 05/2015
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2020 - 01/2020
2	LipidsIBA 01/2020 - 12/2015
2	Amino Acids FDA Link 01/2019 - 12/2015
2	Tyrosine (L-Tyrosine)FDA Link 01/2017 - 01/2015
1	Carnitine (L-Carnitine)FDA LinkGeneric 11/2022
1	IsotopesIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Liver GlycogenIBA 01/2022
1	Transaminases (Aminotransferases)IBA 01/2021
1	EstersIBA 01/2021
1	Nonesterified Fatty Acids (NEFA)IBA 01/2021
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 01/2021
1	Sodium-Glucose Transport ProteinsIBA 01/2020
1	1,5-anhydroglucitolIBA 01/2020
1	1,5-anhydroglucitol-6-phosphateIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2020
1	Vitamin A (Retinol)FDA LinkGeneric 01/2020
1	Gln Transfer RNAIBA 10/2018
1	nitisinone (Orfadin)FDA Link 01/2017
1	Uric Acid (Urate)IBA 01/2017
1	CholesterolIBA 01/2017
1	Palmitoyl Coenzyme A (Palmitoyl CoA)IBA 12/2016
1	acylcarnitineIBA 12/2016
1	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 03/2016
1	DextrinsIBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 05/2015
1	Blood Glucose (Blood Sugar)IBA 05/2015
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2015
1	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2014
1	Ketone BodiesIBA 10/2014
1	Free RadicalsIBA 09/2014
1	AntioxidantsIBA 09/2014
1	Phenylalanine Ammonia-LyaseIBA 07/2014

Therapy/Procedure

2	Precision Medicine 09/2019 - 01/2017
1	Glycemic Control 01/2021
1	Off-Label Use 01/2020
1	Therapeutics 09/2019